Verastem, Inc. Financial Summary

Quick Answer

Verastem, Inc. reported Total Revenue of $30.91 million for fiscal year 2025.

Verastem, Inc. — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $30.91M
+209.1%
$10.00M $2.60M
+26.4%
$2.05M
-97.7%
$88.52M
+407.1%
Revenue (ASC 606) $10.00M $2.60M
+26.4%
$2.05M
-97.7%
$88.52M
+407.1%
Net Income -$209.47M
-60.3%
-$130.64M
-49.5%
-$87.37M
-18.4%
-$73.81M
-3.7%
-$71.20M
-5.1%
-$67.73M
+54.6%
Diluted EPS -$3.02
+17.5%
-$3.66
+7.6%
-$3.96
+13.3%
-$4.57
+6.7%
-$4.90
-1013.6%
-$0.44
+78.0%
Total Assets $246.44M
+142.7%
$101.54M
-32.2%
$149.72M
+57.5%
$95.05M
-12.5%
$108.66M
-29.6%
$154.35M
+6.4%
Cash and Equivalents $204.99M
+130.8%
$88.82M
+14.0%
$77.91M
+4.0%
$74.93M
+252.6%
$21.25M
-68.6%
$67.78M
+55.8%
Long-Term Debt
Stockholders Equity $57.20M
+298.0%
-$28.89M
-150.4%
$57.37M
+21.1%
$47.39M
-45.9%
$87.56M
-24.0%
$115.27M
+1506.8%
R&D Expense $114.60M
+40.9%
$81.33M
+32.6%
$61.36M
+21.4%
$50.56M
+28.5%
$39.35M
-4.9%
$41.38M
-9.6%
Operating Income -$170.13M
-48.0%
-$114.96M
-24.8%
-$92.08M
-26.3%
-$72.94M
-18.8%
-$61.41M
-24.4%
-$49.36M
+62.7%
Shares Outstanding 77.74M
+73.6%
44.78M
+77.1%
25.28M
+51.3%
16.71M
-91.0%
185.29M
+8.7%
170.46M
+112.8%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue September 30, 2025 $11.24M +426.1%
Revenue (ASC 606) June 30, 2024 $10.00M +285.2%
Net Income September 30, 2025 -$98.52M -311.1% -279.9%
Diluted EPS September 30, 2025 -$1.35 -125.0% -117.7%
Total Assets September 30, 2025 $176.85M +39.9% -9.9%
Cash and Equivalents September 30, 2025 $137.71M +21.7% -16.2%
Long-Term Debt September 30, 2018 $21.54M +822.3% -8.4%
Stockholders Equity September 30, 2025 -$15.53M -240.4% -143.1%
R&D Expense September 30, 2025 $28.99M +17.1% +17.0%
Operating Income September 30, 2025 -$40.72M -10.0% +7.0%
Shares Outstanding September 30, 2025 66.75M +65.8% +8.5%
  • Verastem, Inc. reported Total Revenue of $30.91 million for fiscal year 2025.
  • Verastem, Inc. showed an increase of +209.1% in Total Revenue compared to the prior fiscal year.
  • Verastem, Inc. reported Revenue (ASC 606) of $10.00 million for fiscal year 2024.
  • Verastem, Inc. showed an increase of +285.2% in Revenue (ASC 606) compared to the prior fiscal year.
  • Verastem, Inc. reported Net Income of -$209.47 million for fiscal year 2025.
  • Verastem, Inc. showed a decrease of -60.3% in Net Income compared to the prior fiscal year.
  • Verastem, Inc. reported Diluted EPS of $3.02 per share (loss) for fiscal year 2025.
  • Verastem, Inc. showed an increase of +17.5% in Diluted EPS compared to the prior fiscal year.
  • Verastem, Inc. reported Total Assets of $246.44 million for fiscal year 2025.
  • Verastem, Inc. showed an increase of +142.7% in Total Assets compared to the prior fiscal year.
  • Verastem, Inc. reported Cash and Equivalents of $204.99 million for fiscal year 2025.
  • Verastem, Inc. showed an increase of +130.8% in Cash and Equivalents compared to the prior fiscal year.
  • Verastem, Inc. reported Long-Term Debt of $14.83 million for fiscal year 2017.
  • Verastem, Inc. reported Stockholders Equity of $57.20 million for fiscal year 2025.
  • Verastem, Inc. showed an increase of +298.0% in Stockholders Equity compared to the prior fiscal year.
  • Verastem, Inc. reported R&D Expense of $114.60 million for fiscal year 2025.
  • Verastem, Inc. showed an increase of +40.9% in R&D Expense compared to the prior fiscal year.
  • Verastem, Inc. reported Operating Income of -$170.13 million for fiscal year 2025.
  • Verastem, Inc. showed a decrease of -48.0% in Operating Income compared to the prior fiscal year.
  • Verastem, Inc. reported Shares Outstanding of 77.74 million shares for fiscal year 2025.
  • Verastem, Inc. showed an increase of +73.6% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment